Mertens F, Mandahl N, Mitelman F, Heim S
Department of Clinical Genetics, University Hospital, Lund, Sweden.
Pediatr Hematol Oncol. 1994 Jul-Aug;11(4):361-77. doi: 10.3109/08880019409140536.
Although pediatric solid tumors are cytogenetically less well characterized than childhood leukemias, an understanding of the role of chromosomal changes in the development of these neoplasms is emerging. The major clinical importance of chromosome analysis today is diagnostic. Especially in small cell round cell tumors of childhood, the unique karyotypic patterns that characterize some of the differential diagnostic entities make it possible to determine with a high degree of certainty which type of cancer the child has. Molecular studies have revealed that almost all retinoblastomas show homozygous loss of function of the RB1 gene in 13q14. At the cytogenetic level, however, aberrations of 13q are seen in less than 25% of retinoblastomas; instead, the presumably progression-related i(6p) and aberrations leading to gain of 1q predominate, each being present in one-third of the tumors. Twenty percent of cytogenetically aberrant Wilms' tumors show structural rearrangements, often deletions, of 11p13 and 11p15, where the WT1 and WT2 genes map. Other frequent changes are trisomy 12 and duplication of 1q. The most common (80%) cytogenetic abnormality in neuroblastoma is loss of distal 1p, a chromosome segment thought to harbor at least two tumor-suppressor genes of importance in tumorigenesis. Double minute chromosomes or homogeneously staining regions are present in one-third of all neuroblastomas and are associated with MYCN amplification. Loss of 1p material or MYCN amplification predicts a poor outcome. The most common (30%) chromosomal aberration in primitive neuroectodermal tumors of the central nervous system is i(17q). The formation of this isochromosome may help inactivate a tumor-suppressor gene located distal to the TP53 locus on 17p. No specific chromosome abnormality has been detected in gliomas, but monosomy 22 and rearrangements leading to loss of 1p and gain of 1q are recurrent. Few hepatoblastomas with chromosomal changes have been reported, but several potential primary aberrations have been described, including +2, +20, and duplication 8q. In Ewing's sarcoma, t(11;22)(q24;q12) is the primary aberration, with trisomy 8 and gain of 1q being frequent secondary changes. Fibrosarcomas in children often carry only numeric aberrations, especially trisomy for chromosomes 11, 20, 17, and 8. Most osteosarcomas are cytogenetically complex, and no specific abnormality has been detected; the single most common change is loss of chromosome 13, which is observed in half the tumors. In contrast, the low-malignancy parosteal osteosarcomas often display supernumerary ring chromosomes as the sole karyotypic deviation. The cytogenetic profiles of rhabdomyosarcomas differ among the various morphologic subtypes.(ABSTRACT TRUNCATED AT 400 WORDS)
尽管儿科实体瘤在细胞遗传学上的特征不如儿童白血病那样明确,但对染色体变化在这些肿瘤发生发展中所起作用的认识正在不断涌现。如今染色体分析的主要临床重要性在于诊断。特别是在儿童小细胞圆形细胞瘤中,某些鉴别诊断实体所特有的独特核型模式使得能够高度确定地判断儿童患的是哪种类型的癌症。分子研究表明,几乎所有视网膜母细胞瘤在13q14处都显示RB1基因功能的纯合缺失。然而,在细胞遗传学水平上,不到25%的视网膜母细胞瘤可见13q的畸变;相反,可能与进展相关的i(6p)以及导致1q增加的畸变占主导,每种情况在三分之一的肿瘤中出现。20%细胞遗传学异常的肾母细胞瘤显示11p13和11p15的结构重排,通常为缺失,WT1和WT2基因定位于此。其他常见变化包括12号染色体三体和1q重复。神经母细胞瘤最常见的(80%)细胞遗传学异常是1p远端缺失,该染色体片段被认为至少含有两个在肿瘤发生中起重要作用的肿瘤抑制基因。三分之一的神经母细胞瘤存在双微体染色体或均匀染色区,且与MYCN扩增相关。1p物质缺失或MYCN扩增预示预后不良。中枢神经系统原始神经外胚层肿瘤最常见的(30%)染色体畸变是i(17q)。这种等臂染色体的形成可能有助于使位于17p上TP53基因座远端的一个肿瘤抑制基因失活。在胶质瘤中未检测到特定的染色体异常,但22号染色体单体以及导致1p缺失和1q增加的重排较为常见。报道的伴有染色体变化的肝母细胞瘤很少,但已描述了几种潜在的原发性畸变,包括+2、+20和8q重复。在尤因肉瘤中,t(11;22)(q24;q12)是主要畸变,8号染色体三体和增加是常见的继发变化。儿童纤维肉瘤通常仅携带数量畸变,尤其是11、20、17和8号染色体三体。大多数骨肉瘤在细胞遗传学上较为复杂,未检测到特定异常;唯一最常见的变化是13号染色体缺失,在一半的肿瘤中可见。相比之下,低恶性骨旁骨肉瘤常显示额外的环状染色体作为唯一的核型偏差。横纹肌肉瘤的细胞遗传学图谱在不同形态学亚型之间存在差异。(摘要截于400字)